MedTrace Logo

Assessment of ASPIRE and HOPE Adherence

NCT02702895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2022-10-13

No results posted yet for this study

Summary

MTN-032 is an exploratory sub-study of the ASPIRE and HOPE trials that will utilize qualitative In-Depth Interviews (IDIs) and Focus-Group Discussions (FGDs) to explore socio-contextual and trial specific issues which affected participants' adherence to the dapivirine vaginal ring (VR), as well as male partner attitudes towards and experiences with the dapivirine VR and their perspective of their female partner's attitudes and experiences.

Conditions

  • HIV Prevention

Interventions

BEHAVIORAL

In-depth Interview (IDIs) or Focus Group Discussion (FGD)

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Microbicide Trials Network

    lead NETWORK

Principal Investigators

  • Elizabeth Montgomery, PhD, MHS · RTI International

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-13
Primary Completion
2018-12-19
Completion
2019-12-19

Countries

  • Malawi
  • South Africa
  • Uganda
  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02702895 on ClinicalTrials.gov